Cargando…

Riociguat: Something new in pulmonary hypertension therapeutics?

Pulmonary hypertension (PH) continues to be a disease that is associated with woeful outcomes. The search for an ideal drug molecule for PH led to the discovery of riociguat, which is a first-in-class drug molecule that activates soluble guanylate cyclase. We conducted a systematic literature search...

Descripción completa

Detalles Bibliográficos
Autores principales: Shanmugam, Elangovan, Jena, Amrita, George, Melvin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319244/
https://www.ncbi.nlm.nih.gov/pubmed/25709345
http://dx.doi.org/10.4103/0976-500X.149132